Ultragenyx Pharmaceutical Inc.

NEW YORK STATE COMMON RETIREMENT FUND RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

34,024

Value ($000)

783

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	783	0.0%	34,024	12/31/2025
2025 Q3	11/3/2025	1,063	0.0%	35,346	9/30/2025
2025 Q2	10/8/2025	1,416	0.0%	38,946	6/30/2025
2025 Q1	10/8/2025	2,233	0.0%	61,667	3/31/2025
2024 Q4	10/8/2025	2,464	0.0%	58,571	12/31/2024
2024 Q3	10/8/2025	3,531	0.0%	63,571	9/30/2024
2024 Q2	10/8/2025	2,249	0.0%	54,724	6/30/2024
2024 Q1	10/8/2025	2,906	0.0%	62,248	3/31/2024
2023 Q4	10/8/2025	3,484	0.0%	72,866	12/31/2023
2023 Q3	10/8/2025	1,896	0.0%	53,193	9/30/2023
2023 Q2	10/8/2025	2,973	0.0%	64,446	6/30/2023
2023 Q1	10/8/2025	2,499	0.0%	62,329	3/31/2023
2022 Q4	10/8/2025	3,225	0.0%	69,600	12/31/2022
2022 Q3	11/8/2022	5,135	0.0%	123,995	9/30/2022
2022 Q2	8/4/2022	10,418	0.0%	174,630	6/30/2022
2022 Q1	7/1/2022	13,438	0.0%	185,040	3/31/2022
2021 Q4	2/2/2022	15,422	0.0%	183,403	12/31/2021
2021 Q3	11/2/2021	17,267	0.0%	191,446	9/30/2021
2021 Q2	8/2/2021	17,898	0.0%	187,705	6/30/2021
2021 Q1	5/11/2021	17,979	0.0%	157,906	3/31/2021
2020 Q4	2/8/2021	20,461	0.0%	147,806	12/31/2020
2020 Q3	11/5/2020	10,766	0.0%	130,994	9/30/2020
2020 Q2	8/7/2020	10,004	0.0%	127,894	6/30/2020
2020 Q1	5/6/2020	2,195	0.0%	49,400	3/31/2020
2019 Q4	2/5/2020	2,097	0.0%	49,100	12/31/2019